Back

Triglyceride levels predict high-risk coronary artery plaque progression in asymptomatic patients with type 2 diabetes and normal LDL cholesterol

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in acute coronary syndromes (2) Vulnerable Plaque ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Laurits Juhl Heinsen

Svendborg Hospital, Svendborg (Denmark)

8 More presentations in this session

Presentation thumbnail
Temporal trends in severe obesity for patients with ST-elevation myocardial infarctions in patient cohorts stratified by age and gender
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis
Professor Z. Motovska (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Real-world impact on mortality of drug adherence to statin, beta-blocker and ACEi/ARB therapy in post-STEMI patients with preserved EF: results from the FAST STEMI registry.
Doctor G. Giannino (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Referral pathway in primary PCI - delays depend on the origin
Doctor F. Dias Claudio (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Temporal trends in the prevalence of cardiovascular and non-cardiovascular comorbidities in patients presenting with acute myocardial infarction: Insights from the AMIS Plus registry
Mr J. Loosli (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world evidence in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Participant-level pericoronary adipose tissue attenuation predicts changes in plaque composition: a 1-year prospective study in asymptomatic individuals with type 2 diabetes mellitus
thumbnail
Congress Presentation
Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis
thumbnail
Congress Presentation
Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources